Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shubhranshu Zutshi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2021
Revisiting the Principles of Designing a VaccineShubhranshu Zutshi, Sunil Kumar, Prashant Chauhan, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2021
Development of the Antileishmanial VaccineSunil Kumar, Shubhranshu Zutshi, Mukesh Kumar Jha, et al.
Applied Biochemistry and Biotechnology|February 1, 2014
Identification of potential vaccine candidates against Streptococcus pneumoniae by reverse vaccinology approachSandipan Talukdar, Shubhranshu Zutshi, K S Prashanth, et al.
Parasite Immunology|December 5, 2019
Leishmania major adenylate kinase immunization offers partial protection to a susceptible hostShubhranshu Zutshi, Sunil Kumar, Aditya Sarode, et al.
Parasite Immunology|November 27, 2019
LmjMAPK10 offers protection against Leishmania donovani infectionSunil Kumar, Shubhranshu Zutshi, Ashok Patidar, et al.
Indian Journal of Experimental Biology|March 4, 2016
Prevalence and identification of extended spectrum β-lactamases (ESBL) in Escherichia coli isolated from a tertiary care hospital in North-East IndiaRavikant, Parveen Kumar, Swapnil Ranotkar, et al.
Journal of Global Antimicrobial Resistance|November 23, 2016
Vancomycin-resistant enterococci: Troublemaker of the 21st centurySwapnil Ranotkar, Parveen Kumar, Shubhranshu Zutshi, et al.
Vaccines|October 23, 2019
Anti-Leishmanial Vaccines: Assumptions, Approaches, and AnnulmentsShubhranshu Zutshi, Sunil Kumar, Prashant Chauhan, et al.
Iscience|August 23, 2020
Residue-Specific Message Encoding in CD40-LigandAditya Yashwant Sarode, Mukesh Kumar Jha, Shubhranshu Zutshi, et al.
Immunology|March 25, 2021
LmjF.36.3850, a novel hypothetical Leishmania major protein, contributes to the infectionShubhranshu Zutshi, Aditya Yashwant Sarode, Soumya Kanti Ghosh, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2021
Revisiting the Principles of Designing a VaccineShubhranshu Zutshi, Sunil Kumar, Prashant Chauhan, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2021
Development of the Antileishmanial VaccineSunil Kumar, Shubhranshu Zutshi, Mukesh Kumar Jha, et al.
Applied Biochemistry and Biotechnology|February 1, 2014
Identification of potential vaccine candidates against Streptococcus pneumoniae by reverse vaccinology approachSandipan Talukdar, Shubhranshu Zutshi, K S Prashanth, et al.
Parasite Immunology|December 5, 2019
Leishmania major adenylate kinase immunization offers partial protection to a susceptible hostShubhranshu Zutshi, Sunil Kumar, Aditya Sarode, et al.
Parasite Immunology|November 27, 2019
LmjMAPK10 offers protection against Leishmania donovani infectionSunil Kumar, Shubhranshu Zutshi, Ashok Patidar, et al.
Indian Journal of Experimental Biology|March 4, 2016
Prevalence and identification of extended spectrum β-lactamases (ESBL) in Escherichia coli isolated from a tertiary care hospital in North-East IndiaRavikant, Parveen Kumar, Swapnil Ranotkar, et al.
Journal of Global Antimicrobial Resistance|November 23, 2016
Vancomycin-resistant enterococci: Troublemaker of the 21st centurySwapnil Ranotkar, Parveen Kumar, Shubhranshu Zutshi, et al.
Vaccines|October 23, 2019
Anti-Leishmanial Vaccines: Assumptions, Approaches, and AnnulmentsShubhranshu Zutshi, Sunil Kumar, Prashant Chauhan, et al.
Iscience|August 23, 2020
Residue-Specific Message Encoding in CD40-LigandAditya Yashwant Sarode, Mukesh Kumar Jha, Shubhranshu Zutshi, et al.
Immunology|March 25, 2021
LmjF.36.3850, a novel hypothetical Leishmania major protein, contributes to the infectionShubhranshu Zutshi, Aditya Yashwant Sarode, Soumya Kanti Ghosh, et al.
Pageof 1